Literature DB >> 2538191

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.

H E Connor1, W Feniuk, P P Humphrey.   

Abstract

1. The aim of this study was to characterize the 5-hydroxytryptamine (5-HT) receptor which mediates contraction of canine and primate isolated basilar artery by use of a variety of selective 5-HT agonists and antagonists. 2. 5-HT, alpha-methyl 5-HT and the selective 5-HT1-like receptor agonists, GR43175 and 5-carboxamidotryptamine (5-CT), each caused contraction of canine and primate basilar artery with a rank order of agonist potency of 5-CT greater than or equal to 5-HT greater than GR43175 greater than alpha-methyl 5-HT. The 5-HT1-like receptor agonists, GR43175 and 5-CT, produced maximum effects which were less than that produced by 5-HT or alpha-methyl 5-HT. 3. In canine basilar artery, ketanserin (0.1-1 microM) caused some depression of the maximum effect of 5-HT but produced little or no shift of the concentration-effect curve. The contractile effects of GR43175 were not modified by ketanserin (1 microM), MDL72222 (1 microM) or cyanopindolol (1 microM). However, the effects of 5-HT and GR43175 were specifically antagonized by methiothepin (0.1 microM); the mean agonist concentration-ratios were 33 and 48 respectively. 4. In primate basilar artery, ketanserin (1 microM) again caused a small depression of the 5-HT maximum response but had not effect against GR43175-induced contractions. In contrast, methiothepin (0.1 microM) antagonized both 5-HT- and GR43175-induced contractions; the mean agonist concentration-ratios were 35 for both. 5. These results demonstrate that a large component of the effects of 5-HT in canine and primate basilar artery is produced by stimulation of a 5-HT1-like receptor. This receptor can be characterized by the high potency of the novel, selective agonist, GR43175, and susceptibility to blockade by methiothepin. However, there also appears to be a population of 5-HT2 receptors in these prepAarations which contribute to the contractile effects of 5-HT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538191      PMCID: PMC1854374          DOI: 10.1111/j.1476-5381.1989.tb11828.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.

Authors:  D N Middlemiss; J R Fozard
Journal:  Eur J Pharmacol       Date:  1983-05-20       Impact factor: 4.432

2.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex.

Authors:  E Schlicker; M Göthert; K Hillenbrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

3.  Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors.

Authors:  S J Peroutka; M Noguchi; D J Tolner; G S Allen
Journal:  Brain Res       Date:  1983-01-24       Impact factor: 3.252

4.  Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.

Authors:  E Müller-Schweinitzer; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

5.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

6.  A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.

Authors:  W Feniuk; P P Humphrey; M J Perren; A D Watts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

7.  Dissociation constants of serotonin agonists in the canine basilar artery correlate to Ki values at the 5-HT1A binding site.

Authors:  E W Taylor; S P Duckles; D L Nelson
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

8.  Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

9.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

View more
  28 in total

1.  Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.

Authors:  S Hood; D Birnie; L S Murray; P D MacIntyre; W S Hillis
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  [PET and Doppler sonography in headaches].

Authors:  A May; C Weiller
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

3.  Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.

Authors:  E Hamel; D Bouchard
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 4.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

5.  Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.

Authors:  V F Cosson; E Fuseau; C Efthymiopoulos; A Bye
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

6.  The vasomotor effects of 5-hydroxytryptamine on equine basilar arteries in vitro.

Authors:  A Miyamoto; T Obi; A Nishio
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

7.  How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

8.  Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.

Authors:  M O den Boer; C M Villalón; J P Heiligers; P P Humphrey; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

9.  5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery.

Authors:  I Sahin-Erdemli; D Hoyer; A Stoll; M P Seiler; P Schoeffter
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

10.  Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat.

Authors:  M Kobari; Y Fukuuchi; M Tomita; N Tanahashi; S Konno; H Takeda
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.